| Page | |||||
|---|---|---|---|---|---|
| Reference | and Administrative Details |
||||
| Report of | the Trustees | 2 | to | 3 | |
| Report of | the Independent Auditors |
4 | to | 6 | |
| Statement | of Financial | Activities | |||
| Balance Sheet | |||||
| Notes to the Financial | Statements | 9 | to | 14 |
| S | PARC AUTISM | |||||
|---|---|---|---|---|---|---|
| Reference | and Administrative | Details | ||||
| for the | ear ended 31 March | 2021 | ||||
| Trustees | Dr A Roy | |||||
| G Singh | ||||||
| J A Thronicker | ||||||
| Ms KJ Hawkes | (appointed | 8/12/2020) | ||||
| Registered | office | Imperial Court |
||||
| 10Sovereign Road | ||||||
| Kings Norton Business Centre | ||||||
| Birmingham | ||||||
| B303ES | ||||||
| Registered | company | number | 08414424 | |||
| Registered | charity number | 1160495 | ||||
| Auditors | Haines Watts Birmingham | LLP | ||||
| 5-6 Greenfield | Crescent | |||||
| Edgbaston | ||||||
| Birmingham | ||||||
| B153BE | ||||||
| Bankers | The Co-Operative | Bank Pic | ||||
| 118/120 Colmore | Row | |||||
| Birmingham | ||||||
| B33BA |
| SPA | SPA | SPA | RC AUTISM | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Statement | of Financial | Activities | |||||||
| for | the | ear | ended 31 March 2021 | ||||||
| 2021 | 2020 | ||||||||
| Unrestricted | |||||||||
| fund | Total funds | ||||||||
| Notes | f. | ||||||||
| Income and endowments | from | ||||||||
| Charitable activities |
|||||||||
| Autism diagnostic assessment |
services | 46,150 | 48,825 | ||||||
| Expenditure on |
|||||||||
| Charitable activities |
|||||||||
| Autism diagnostic assessment |
services | 50,687 | 51,303 | ||||||
| NET INCOME/(EXPENDITURE) | (4,537) | (1,478) | |||||||
| Reconciliation offunds |
|||||||||
| Total funds brought forward |
27,560 | 29,038 | |||||||
| Total funds carried forward | 23,023 | 27,560 | |||||||
| Continuing operations |
|||||||||
| All income and expenditure | has | arisen | from continuing | activities. | |||||
| The Statement of Financial |
Activities | includes | all | gains | and losses | recognised | in the year. |
| SPARC AUTISM | ||||
|---|---|---|---|---|
| Balance Sheet | ||||
| 31 March 2021 | ||||
| 2021 | 2020 | |||
| Unrestricted | ||||
| Notes | fundf | Total funds | ||
| Current assets | ||||
| Debtors | 43,982 | 26,229 | ||
| Cash at bank | 12,346 | 21,481 | ||
| 56,328 | 47,710 | |||
| Creditors | ||||
| Amounts falling due within one year |
10 | (33,305) | (20,150) | |
| Net current | assets | 23,023 | 27,560 | |
| Total assets | less current liabilities | 23,023 | 27,560 | |
| NET ASSETS | 23,023 | 27,560 | ||
| Funds | ||||
| Unrestricted | funds | 23,023 | 27,560 | |
| Total funds | 23,023 | 27,560 |
| 2021 | 2020 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Activity | ||||||||||||
| Assessment | income | Autism | diagnostic assessment | services | 46,150 | 49,825 | ||||||
| 3. | Charitable | activities costs | ||||||||||
| Direct | Support | |||||||||||
| Costs (see | costs (see | |||||||||||
| note 4)f | note 5) | Totals | ||||||||||
| Autism | diagnostic assessment | services | 26,620 | 24,067 | 50,687 | |||||||
| 4. | Direct costs | ofcharitable | activities | |||||||||
| 2021f | 2020 | |||||||||||
| Clinician | fees | 26,620 | 28,010 | |||||||||
| 5. | Support | costs | ||||||||||
| Governance | ||||||||||||
| Management | Finance | Otherf | costsf | Totals | ||||||||
| Autism | diagnostic | |||||||||||
| assessment | services | 20,304 | 98 | 2,225 | 1,440 | 24,067 | ||||||
| Support | costs, included | in the | above, are as follows: | |||||||||
| 2021 | 2020 | |||||||||||
| Autism | ||||||||||||
| diagnostic | ||||||||||||
| assessment | Total | |||||||||||
| services | activities | |||||||||||
| Office and | administration | 20,304 | 19,500 | |||||||||
| Bank charges | 98 | 129 | ||||||||||
| Insurance | 2,225 | 2,214 | ||||||||||
| Auditors' | remuneration | 1,440 | 1,450 | |||||||||
| 24,067 | 23,293 |
| 6. | Net income/(expenditure) | Net income/(expenditure) | Net income/(expenditure) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income/(expenditure) is stated |
after | charging/(crediting): | |||||||||||
| 2021 | 2020 | ||||||||||||
| 6 | |||||||||||||
| Auditors' remuneration |
1,440 | 1,450 | |||||||||||
| 7. | Trustees' remuneration and benefits |
||||||||||||
| There was no trustees' remuneration |
or employee | benefits | paid for the year ended 31 March | 2021 nor for | th | ||||||||
| year ended 31 March 2020. | |||||||||||||
| Trustees' expenses | |||||||||||||
| During the period the company | incurred | clinical fees | totalling | Enil (2020 - f10,480) which were | payable to 2 | o | |||||||
| the trustees in the course of normal |
charitable | activities. | |||||||||||
| At the year-end anil (2020 - anil) |
was owed to | trustees | in respect of clinician fees payable. | ||||||||||
| Comparatives for the statement |
offinancial | activities | |||||||||||
| Unrestricted | |||||||||||||
| fund | |||||||||||||
| E | |||||||||||||
| Income and endowments from |
|||||||||||||
| Charitable activities |
|||||||||||||
| Autism diagnostic assessment |
services | 49,825 | |||||||||||
| Expenditure on |
|||||||||||||
| Charitable activities |
|||||||||||||
| Autism diagnostic assessment |
services | 51,303 | |||||||||||
| NET INCOME/(EXPENDITURE) | (1,478) | ||||||||||||
| Reconciliation offunds |
|||||||||||||
| Total funds brought forward |
29,038 | ||||||||||||
| Total funds carried forward | 27,560 | ||||||||||||
| 9. | Debtors: amounts falling due |
within | one year | ||||||||||
| 2021 E |
2020f | ||||||||||||
| Trade debtors | 43,425 | 25,674 | |||||||||||
| Prepayments and accrued income |
557 | 555 | |||||||||||
| 43,982 | 26,229 |
| 2021 | 2020f | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade creditors | 31,965 | 18,810 | ||||||||||
| Accruals and | deferred | income | 1,340 | 1,340 | ||||||||
| 33,305 | 20,150 | |||||||||||
| 11. | Movement | In funds | ||||||||||
| Net | ||||||||||||
| movement | ||||||||||||
| At 1/4/20 | in funds | At 31/3/21 | ||||||||||
| E' | ||||||||||||
| Unrestricted | funds | |||||||||||
| General fund |
27,560 | (4,537) | 23,023 | |||||||||
| TOTAL FUNDS | 27,560 | (4,537) | 23,023 | |||||||||
| Net movement | in funds, | included | in | the above | are as follows: | |||||||
| Incoming | Resources | Movement | ||||||||||
| resources | expended | in funds | ||||||||||
| Unrestricted | funds | |||||||||||
| General fund |
46,150 | (50,687) | (4,537) | |||||||||
| TOTAL FUNDS | 46,150 | (50,687) | (4,537) | |||||||||
| Comparatives | for movement | in | funds | |||||||||
| Net | ||||||||||||
| movement | ||||||||||||
| At 1/4/19 | in funds | At 31/3/20 | ||||||||||
| Unrestricted | funds | |||||||||||
| General fund |
29,038 | (1,478) | 27,560 | |||||||||
| TOTAL FUNDS | 29,038 | (1,478) | 27,560 | |||||||||
| Comparative | net movement | in | funds, | included | in the above are as follows: | |||||||
| Incoming | Resources | Movement | ||||||||||
| resources | expended | in funds | ||||||||||
| Unrestricted | funds | |||||||||||
| General fund |
49,825 | (51,303) | (1,478) | |||||||||
| TOTAL FUNDS | 49,825 | (51,303) | (1,478) |
| A curren | t yea | r 12 months and prior year 12 |
months combined position |
is as foll | ows: | |
|---|---|---|---|---|---|---|
| Net | ||||||
| movement | ||||||
| At | 1/4/19f | in funds | At 31/3/21 | |||
| Unrestricted | funds | |||||
| General | fund | 29,038 | (6,015) | 23,023 | ||
| TOTAL | FUNDS | 29,038 | (6,015) | 23,023 |
| Incoming | Resources | Movement | |||
|---|---|---|---|---|---|
| resourcesf | expended | in funds | |||
| Unrestricted | funds | ||||
| General | fund | 95,975 | (101,990) | (6,015) | |
| TOTAL | FUNDS | 95,975 | (101,990) | (6,015) |